CME Group Inc (NASDAQ:CME) Shares Sold by AGF Investments Inc.

AGF Investments Inc. decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 21.1% in the 2nd quarter, according to the company in its …

CME Group logoAGF Investments Inc. decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 21.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,500 shares of the financial services provider’s stock after selling 400 shares during the period. AGF Investments Inc.’s holdings in CME Group were worth $291,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the business. Independent Advisor Alliance raised its holdings in CME Group by 5.9% during the first quarter. Independent Advisor Alliance now owns 1,947 shares of the financial services provider’s stock valued at $321,000 after acquiring an additional 108 shares during the period. Fox Run Management L.L.C. purchased a new position in CME Group in the second quarter worth about $571,000. Jackson Hole Capital Partners LLC grew its position in CME Group by 4.1% in the first quarter. Jackson Hole Capital Partners LLC now owns 1,986 shares of the financial services provider’s stock worth $327,000 after acquiring an additional 79 shares in the last quarter. KC Investment Advisors LLC grew its position in CME Group by 9.0% in the first quarter. KC Investment Advisors LLC now owns 2,898 shares of the financial services provider’s stock worth $477,000 after acquiring an additional 240 shares in the last quarter. Finally, United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its position in CME Group by 609.0% in the first quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 122,785 shares of the financial services provider’s stock worth $20,208,000 after acquiring an additional 105,468 shares in the last quarter. 85.72% of the stock is owned by institutional investors.

Several research analysts recently commented on the company. Deutsche Bank lifted their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. UBS Group lifted their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 3rd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a research report on Monday, May 27th. Finally, Wells Fargo & Co lifted their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. CME Group has an average rating of “Hold” and an average target price of $194.00.

Shares of CME opened at $215.76 on Thursday. The company’s fifty day moving average price is $207.88 and its 200-day moving average price is $188.20. The firm has a market capitalization of $75.64 billion, a PE ratio of 31.64, a price-to-earnings-growth ratio of 4.70 and a beta of 0.23. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $217.65. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.74 earnings per share. As a group, research analysts anticipate that CME Group Inc will post 6.68 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a $0.75 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio (DPR) is currently 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares in the company, valued at approximately $15,823,258.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Kevin Kometer sold 16,140 shares of the company’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $201.19, for a total transaction of $3,247,206.60. Following the transaction, the insider now owns 72,122 shares of the company’s stock, valued at approximately $14,510,225.18. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,771 shares of company stock valued at $15,398,375. Insiders own 1.20% of the company’s stock.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Why is total return important?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Doliver Advisors LP Increases Stock Holdings in CME Group Inc (NASDAQ:CME)

Doliver Advisors LP lifted its stake in CME Group Inc (NASDAQ:CME) by 18.9% in the second quarter, according to its most recent disclosure with the …

CME Group logoDoliver Advisors LP lifted its stake in CME Group Inc (NASDAQ:CME) by 18.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,400 shares of the financial services provider’s stock after purchasing an additional 698 shares during the quarter. Doliver Advisors LP’s holdings in CME Group were worth $854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Ballentine Partners LLC bought a new position in CME Group during the second quarter valued at approximately $313,000. Wetherby Asset Management Inc. raised its position in CME Group by 2.8% during the second quarter. Wetherby Asset Management Inc. now owns 5,287 shares of the financial services provider’s stock valued at $1,026,000 after acquiring an additional 145 shares in the last quarter. Appleton Partners Inc. MA raised its position in CME Group by 1.3% during the second quarter. Appleton Partners Inc. MA now owns 15,289 shares of the financial services provider’s stock valued at $2,968,000 after acquiring an additional 190 shares in the last quarter. Royal Bank of Scotland Group PLC raised its position in CME Group by 1.3% during the second quarter. Royal Bank of Scotland Group PLC now owns 75,702 shares of the financial services provider’s stock valued at $14,695,000 after acquiring an additional 960 shares in the last quarter. Finally, Arizona State Retirement System raised its position in CME Group by 1.1% during the second quarter. Arizona State Retirement System now owns 127,055 shares of the financial services provider’s stock valued at $24,663,000 after acquiring an additional 1,357 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

Several brokerages recently weighed in on CME. Deutsche Bank raised their price objective on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a research report on Monday, May 27th. Wells Fargo & Co lifted their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Finally, Barclays lifted their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $194.00.

In other CME Group news, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total transaction of $108,005.00. Following the completion of the sale, the director now directly owns 14,593 shares of the company’s stock, valued at approximately $3,152,233.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Bitsberger sold 700 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total value of $136,045.00. Following the sale, the director now directly owns 9,421 shares of the company’s stock, valued at $1,830,971.35. The disclosure for this sale can be found here. Insiders sold 76,771 shares of company stock valued at $15,398,375 over the last ninety days. 1.20% of the stock is currently owned by company insiders.

CME Group stock opened at $215.76 on Thursday. The stock has a 50-day simple moving average of $207.88 and a 200 day simple moving average of $188.20. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $217.65. The stock has a market capitalization of $75.64 billion, a price-to-earnings ratio of 31.64, a P/E/G ratio of 4.70 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the previous year, the business posted $1.74 earnings per share. The firm’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that CME Group Inc will post 6.68 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Purposes and Functions of the Federal Reserve

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Value Composite Update on CME Group Inc. (NasdaqGS:CME) and CVS Health Corporation …

CME Group Inc. (NasdaqGS:CME) currently has a Value Composite score of 67. Similarly, the Value Composite Two (VC2) is calculated with the same …

CME Group Inc. (NasdaqGS:CME) currently has a Value Composite score of 67. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of CME Group Inc. (NasdaqGS:CME) is 71.

Volatility comes with the territory when trading stocks. Individual stock prices can fluctuate dramatically, and returns can be largely varied. Because no stock is guaranteed to produce returns, there is a possibility that any stock could potentially lose value. Even though stock prices can shift from day to day, long-term investors are usually more concerned about price movements over an expanded period of time. Investors looking to minimize volatility risk may look to hold a larger number of diversified stocks in the portfolio. Even though market dips may have an impact on the entire portfolio, it is important to remember that it is just a normal part of investing in the stock market.

In taking a look at some other notable technicals, CME Group Inc. (NasdaqGS:CME)’s ROIC is 0.627276. The ROIC 5 year average is 0.553416 and the ROIC Quality ratio is 12.236357. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a firm is at turning capital into profits.

The Q.i. Value of CME Group Inc. (NasdaqGS:CME) is 48.00000. The Q.i. Value is a helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be.

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of CME Group Inc. (NasdaqGS:CME) is 0.014498.

Shareholder Yield

We also note that CME Group Inc. (NasdaqGS:CME) has a Shareholder Yield of -0.032643 and a Shareholder Yield (Mebane Faber) of -0.04651. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

MF Rank

CME Group Inc. (NasdaqGS:CME) has a current MF Rank of 4882. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

PI

We can now take aquick look at some historical stock price index data. CME Group Inc. (NasdaqGS:CME) presently has a 10 month price index of 1.22733. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period.

A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.30230, the 24 month is 1.78910, and the 36 month is 2.16917. Narrowing in a bit closer, the 5 month price index is 1.33307, the 3 month is 1.15866, and the 1 month is currently 1.08305.

Volatility comes with the territory when trading stocks. Individual stock prices can fluctuate dramatically, and returns can be largely varied. Because no stock is guaranteed to produce returns, there is a possibility that any stock could potentially lose value. Even though stock prices can shift from day to day, long-term investors are usually more concerned about price movements over an expanded period of time. Investors looking to minimize volatility risk may look to hold a larger number of diversified stocks in the portfolio. Even though market dips may have an impact on the entire portfolio, it is important to remember that it is just a normal part of investing in the stock market.

Taking a look at valuation rankings for CVS Health Corporation (NYSE:CVS), we see that the stock has a Value Composite score of 20. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 35.

Technicals



Volatility comes with the territory when trading stocks. Individual stock prices can fluctuate dramatically, and returns can be largely varied. Because no stock is guaranteed to produce returns, there is a possibility that any stock could potentially lose value. Even though stock prices can shift from day to day, long-term investors are usually more concerned about price movements over an expanded period of time. Investors looking to minimize volatility risk may look to hold a larger number of diversified stocks in the portfolio. Even though market dips may have an impact on the entire portfolio, it is important to remember that it is just a normal part of investing in the stock market.

In taking a look at some other notable technicals, CVS Health Corporation (NYSE:CVS)’s ROIC is 0.191774. The ROIC 5 year average is 0.565074 and the ROIC Quality ratio is 17.327644. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a firm is at turning capital into profits.

We also note that CVS Health Corporation (NYSE:CVS) has a Shareholder Yield of -0.244905 and a Shareholder Yield (Mebane Faber) of -0.59285. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

CVS Health Corporation (NYSE:CVS) has a current MF Rank of 4287. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

We can now take a quick look at some historical stock price index data. CVS Health Corporation (NYSE:CVS) presently has a 10 month price index of 0.86036. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.81674, the 24 month is 0.83740, and the 36 month is 0.69956. Narrowing in a bit closer, the 5 month price index is 1.12800, the 3 month is 1.13264, and the 1 month is currently 1.05208.

The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of CVS Health Corporation (NYSE:CVS) is 3.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.

Investors might be trying to figure out the best way to approach the stock market. After creating a plan that includes a list of stocks to purchase, investors may be looking to gauge the best time to enter the trade. With markets still cruising along at high altitudes, investors may be worried about buying at the top. Most individuals would probably agree that getting out before the market drops would be the best play. Obviously this is much easier said than done. If the warning signs were blatant, everyone would know exactly when to sell and when to re-buy. When the stock market has a big decline, the natural instinct is generally to sell in order to protect gains or eliminate further losses. Trying to time the market can have negative implications for investors who are not prepared to handle extremely volatile market conditions. Being prepared for any sudden change in the overall economy or stock market conditions may help the investor stay afloat for the long haul.

Related Posts:

  • No Related Posts

CME Group Inc (CME) CMF Reading Holds Above Zero

CME Group Inc (CME) shares are seeing solid buying inflow as the Chaikin Money Index is holding above zero. If the price consistently closes in the …

CME Group Inc (CME) shares are seeing solid buying inflow as the Chaikin Money Index is holding above zero. If the price consistently closes in the upper half of the daily range on high volume the indicator would read above zero and indicates a strong market. When the indicator stays above zero for a sustained period of time, especially with increasing indicator values, it shows a strong uptrend.

Chaikin Money Flow (CMF), created by Marc Chaikin, is a technical analysis indicator used to measure Money Flow Volume over a window of time. It attempts to measure buying and selling pressures of a security for single period. CMF then sums Money Flow Volume over a user-defined number of periods and divides by the total volume for that number of periods. The result varies between 1 and -1.

Turning to some additional technicals, at the time of writing, the 14-day ADX for CME Group Inc (CME) is 25.68. Many technical chart analysts believe that an ADX value over 25 would suggest a strong trend. A reading under 20 would indicate no trend, and a reading from 20-25 would suggest that there is no clear trend signal. The ADX is typically plotted along with two other directional movement indicator lines, the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI). Some analysts believe that the ADX is one of the best trend strength indicators available.

One of the most famous sayings in the stock market is “buy low, sell high”. This may seem like an oversimplified statement, but there are many novice investors who often do the complete opposite. Many investors may be looking too closely at stocks that have been on the rise, and they might not be checking on the underlying fundamental data. They may be hoping to ride the wave higher, but may end up shaking their heads. On the flip side, many investors may hold onto stocks for far too long after they have slipped drastically. Waiting for a bounce that may never come can cause frustration and plenty of second guessing. Successful investors are typically able to locate stocks that are undervalued at a certain price. This may take a lot of practice and dedication, but it may do wonders for the health of the portfolio.

Some investors may find the Williams Percent Range or Williams %R as a helpful technical indicator. Presently, CME Group Inc (CME)’s Williams Percent Range or 14 day Williams %R is resting at -13.52. Values can range from 0 to -100. A reading between -80 to -100 may be typically viewed as strong oversold territory. A value between 0 to -20 would represent a strong overbought condition. As a momentum indicator, the Williams R% may be used with other technicals to help define a specific trend.

When performing stock analysis, investors and traders may opt to view technical levels. CME Group Inc (CME) presently has a 14-day Commodity Channel Index (CCI) of 128.73. Investors and traders may use this indicator to help spot price reversals, price extremes, and the strength of a trend. Many investors will use the CCI in conjunction with other indicators when evaluating a trade. The CCI may be used to spot if a stock is entering overbought (+100) and oversold (-100) territory.

Checking in on moving averages, the 200-day is at 187.23, the 50-day is 204.63, and the 7-day is sitting at 214.19. Moving averages may be used by investors and traders to shed some light on trading patterns for a specific stock. Moving averages can be used to help smooth information in order to provide a clearer picture of what is going on with the stock. Technical stock analysts may use a combination of different time periods in order to figure out the history of the equity and where it may be headed in the future. MA’s can be calculated for any time period, but two very popular time frames are the 50-day and 200-day moving averages.

Shifting gears to the Relative Strength Index, the 14-day RSI is currently sitting at 61.12, the 7-day is 63.43, and the 3-day is currently at 73.60 for CME Group Inc (CME). The Relative Strength Index (RSI) is a highly popular momentum indicator used for technical analysis. The RSI can help display whether the bulls or the bears are currently strongest in the market. The RSI may be used to help spot points of reversals more accurately. The RSI was developed by J. Welles Wilder. As a general rule, an RSI reading over 70 would signal overbought conditions. A reading under 30 would indicate oversold conditions. As always, the values may need to be adjusted based on the specific stock and market. RSI can also be a valuable tool for trying to spot larger market turns.

One of the most famous sayings in the stock market is “buy low, sell high”. This may seem like an oversimplified statement, but there are many novice investors who often do the complete opposite. Many investors may be looking too closely at stocks that have been on the rise, and they might not be checking on the underlying fundamental data. They may be hoping to ride the wave higher, but may end up shaking their heads. On the flip side, many investors may hold onto stocks for far too long after they have slipped drastically. Waiting for a bounce that may never come can cause frustration and plenty of second guessing. Successful investors are typically able to locate stocks that are undervalued at a certain price. This may take a lot of practice and dedication, but it may do wonders for the health of the portfolio.

Related Posts:

  • No Related Posts

First Merchants Corp Has $390000 Stock Holdings in CME Group Inc (NASDAQ:CME)

First Merchants Corp cut its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% in the second quarter, according to the company in its most …

CME Group logoFirst Merchants Corp cut its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,008 shares of the financial services provider’s stock after selling 192 shares during the period. First Merchants Corp’s holdings in CME Group were worth $390,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Truvestments Capital LLC purchased a new stake in CME Group during the first quarter valued at approximately $32,000. Close Asset Management Ltd purchased a new stake in CME Group during the first quarter valued at approximately $34,000. Westside Investment Management Inc. purchased a new stake in CME Group during the second quarter valued at approximately $38,000. Permanens Capital L.P. purchased a new stake in CME Group during the first quarter valued at approximately $41,000. Finally, Berman Capital Advisors LLC raised its holdings in shares of CME Group by 23.9% in the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after buying an additional 66 shares during the period. 85.72% of the stock is owned by institutional investors.

In other news, COO Julie Holzrichter sold 4,241 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $192.26, for a total value of $815,374.66. Following the completion of the sale, the chief operating officer now owns 46,113 shares of the company’s stock, valued at approximately $8,865,685.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,771 shares of company stock worth $15,398,375. 1.20% of the stock is owned by company insiders.

CME has been the topic of several recent analyst reports. UBS Group increased their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Barclays increased their target price on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Deutsche Bank increased their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Wells Fargo & Co raised their price objective on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $194.00.

Shares of CME stock opened at $215.76 on Thursday. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $217.65. The company has a market cap of $75.64 billion, a P/E ratio of 31.64, a PEG ratio of 4.70 and a beta of 0.23. The firm has a fifty day moving average price of $207.88 and a 200 day moving average price of $188.20. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the company posted $1.74 earnings per share. The firm’s revenue for the quarter was up 20.1% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc will post 6.68 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Market Perform

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts